; 10.1152/ajpgi.00251.2003.-PKC has been shown to regulate epithelial Cl Ϫ secretion in a variety of models. However, the role of PKC in duodenal mucosal bicarbonate secretion is less clear. We aimed to investigate the role of PKC in regulation of duodenal mucosal bicarbonate secretion. Bicarbonate secretion by murine duodenal mucosa was examined in vitro in Ussing chambers using a pH-stat technique. PKC isoform expression and activity were assessed by Western blotting and in vitro kinase assays, respectively. PMA (an activator of PKC) alone had no effect on duodenal bicarbonate secretion or short-circuit current (Isc). When PMA and dibutyrylcAMP (db-cAMP) were added simultaneously, PMA failed to alter db-cAMP-stimulated duodenal bicarbonate secretion or Isc (P Ͼ 0.05). However, a 1-h preincubation with PMA potentiated db-cAMPstimulated duodenal bicarbonate secretion and Isc in a concentrationdependent manner (from 10 Ϫ8 to 10 Ϫ5 M) (P Ͻ 0.05). PMA preincubation had no effects on carbachol-or heat-stable toxin-stimulated bicarbonate secretion. Western blot analysis revealed that PKC␣, -␥, -⑀, -, -, and -/ were expressed in murine duodenal mucosa. Ro 31-8220 (an inhibitor active against PKC⑀, -␣, -␤, and -␥), but not Gö 6983 (an inhibitor active against PKC␣, -␥, -␤, and -␦), reversed the potentiating effect of PMA on db-cAMP-stimulated bicarbonate secretion. PMA also time-and concentration-dependently increased the activity of PKC⑀, an effect that was prevented by Ro 31-8220 but not Gö 6983. These results demonstrate that activation of PKC potentiates cAMP-stimulated duodenal bicarbonate secretion, whereas it does not modify basal secretion. The effect of PKC on cAMP-stimulated bicarbonate secretion is mediated by the PKC⑀ isoform.
SECRETION OF BICARBONATE by the epithelium is an important defensive factor in duodenal mucosal protection against acid-peptic damage. Duodenal bicarbonate secretion is regulated by a number of agents including PGE 2 , cAMP, heat-stable toxin of Escherichia coli (ST a ), guanylin, and carbachol (12, 16, 26, 37) .
PKC consists of a family of phospholipid-dependent serinethreonine kinases, which are widely distributed in mammalian tissues in a cell-specific pattern. At least 11 isoforms of PKC are currently known, and these are usually categorized into three distinct subtypes: conventional PKC (cPKC) isozymes (␣, ␤, and ␥), novel PKC (nPKC) isozymes (␦, ⑀, , , and ), and atypical PKC (aPKC) isozymes ( and /) (25, 31) .
Although PKC isoforms have many structurally similar elements, they vary in their sensitivity to activators and cofactors. cPKCs require Ca 2ϩ for their activation, whereas nPKCs can be activated without Ca 2ϩ . Both cPKCs and nPKCs can be activated by phorbol 12-myristate 13-acetate (PMA). aPKCs require only phosphatidylserine for activation and, as a general rule, cannot be activated directly by PMA. PKC plays a key role in the regulation of ion transport, cell growth, and differentiation. It profoundly altered epithelial Cl Ϫ secretion (22, 2) and potentiated secretory responses evoked by cAMP in T84 (6) , C127 (7) , and pancreatic duct cells (36) . In the gastrointestinal tract, PKC is also involved in regulation of gastric acid and pepsinogen secretion (21, 30) . However, the role of PKC in duodenal mucosal bicarbonate secretion is less clear.
Goals of the present study were to 1) investigate the role of PKC in duodenal bicarbonate secretion, 2) define which PKC isoforms are expressed in the duodenal mucosa, and 3) investigate which PKC isoform(s) participate in the regulation of duodenal bicarbonate secretion.
MATERIALS AND METHODS
Chemicals and solutions. PMA, dibutyryl-cAMP (db-cAMP), carbachol, ST a, and myelin basic protein were purchased from Sigma (St. Louis, MO). Ro 31-8220 and Gö 6983 were from Calbiochem (San Diego, CA). Monoclonal antibodies directed against PKC isoforms ␣, ␤, ␥, ␦, ⑀, , , and / were from Transduction Laboratories (Lexington, KY). [␥Ϫ 32 P]ATP, with a specific activity of 3,000 Ci/mmol, was purchased from New England Nuclear (Boston, MA). All other chemicals were obtained from Fisher Scientific (Santa Clara, CA). For Ussing chamber studies, the mucosal solution contained the following (in mM): 140 Na ϩ , 5. Animal preparation. Experiments were performed on White Swiss mice (6-10 wk of age). All studies were approved by the University of California, San Diego, Committee on Investigations Involving Animals. The mice were housed in a standard animal care room with a 12:12-h light-dark cycle and were allowed free access to food and water. Before experiments, the mice were deprived of food and water for Յ1 h. After anesthesia with a cocktail of hypnorm and midazolam (10 ml/kg ip), the abdomen was opened by midline incision. The proximal duodenum (a portion stretching approximately from 2 mm distal to the pylorus to the common bile duct ampulla) was removed and immediately placed in ice-cold isosmolar mannitol and indomethacin (1 M) solution (to suppress trauma-induced prostaglandin release). The anesthetized mice were then killed by cervical disloca-tion. The duodenum was opened along the mesenteric border and stripped of external serosal and muscle layers by sharp dissection in the above mentioned ice-cold isosmolar mannitol and indomethacin solution.
Ussing chamber experiments. The mucosa was mounted between two Lucite half chambers with an exposed area of 0.1 cm 2 and placed in an Ussing chamber. The duodenal tissue from each animal was randomly divided among three chambers for experiments. The mucosal side was bathed with unbuffered bicarbonate-free modified Ringers solution circulated by a gas lift with 100% O 2. The serosal side was bathed with modified buffered Ringers solution (pH 7.4) containing 25 mM HCO 3 Ϫ and gassed with 95% O2-5% CO2. Each bath contained 3.0 ml of the respective solution maintained at 37°C by a heated water jacket. Experiments were performed under continuous short-circuited conditions (Voltage-Current Clamp, model VCC 600; Physiological Instruments, San Diego, CA) to maintain the electrical potential difference at zero, except for a brief period (Ͻ2 s) at each time point when the open-circuit potential difference was measured. Luminal pH was maintained at 7.40 by the continuous infusion of 5 mM HCl under the automatic control of a pH-stat system (model ETS 822; Radiometer America, Westlake, OH). The volume of the titrant infused per unit time was used to quantitate bicarbonate secretion. These measurements were recorded at 5-min intervals, and mean values for consecutive 10-min periods were calculated. The rate of luminal bicarbonate secretion is expressed as micromoles per square centimeter per hour. Short-circuit current (I sc) was measured in microamperes and converted into microequivalents per square centimeter per hour, and potential difference was measured in millivolts.
To Western blot analysis. Segments of duodenal tissue (ϳ25 mg) were stripped of seromuscular layers as described above for Ussing chamber experiments. Tissue samples were frozen immediately in liquid nitrogen. Protein was extracted by homogenization on ice in 500 l lysis buffer containing (in mM) 20 Tris⅐HCl (pH 7.5), 150 NaCl, 1 disodium EDTA, 1 EGTA, 2.5 sodium pyrophosphate, 1 ␤-glycerophosphate, 1 sodium orthovanadate, and 1% Triton X-100, and complete protease inhibitor cocktail (Sigma, St. Louis, MO). Equal amounts of protein, as determined by Lowry assay (Dc assay; BioRad, Hercules, CA), were combined with 2ϫ Laemmli sample buffer and boiled for 5 min. Proteins were separated by electrophoresis on 7.5% SDS-PAGE gels and transblotted to nitrocellulose membranes. The protein-bound nitrocellulose sheets were first incubated overnight at 4°C in blocking buffer containing 5% nonfat dry milk in distilled water. Nitrocellulose sheets were then incubated with monoclonal antibodies to different PKC isoforms diluted in blocking buffer (1:1,000) for 1 h at room temperature and rinsed for 1 h with a wash buffer containing 20 mM Tris, pH 7.5, 500 mM NaCl, and 1% Tween 20. The membranes were then incubated with horseradish peroxidaseconjugated goat anti-rabbit IgG antibody for 30 min at room temperature and washed for 1 h with agitation, changing the wash buffer every 15 min. PKC bands were visualized with ECL Plus detection reagents (Amersham, Pharmacia, Piscataway, NJ).
In vitro kinase assay. After incubation with PMA, duodenal mucosal samples were frozen immediately in liquid nitrogen. When PKC inhibitors were used, the tissue was preincubated with the PKC inhibitor for 30 min before PMA. Protein was extracted by homogenization on ice in 500 l lysis buffer containing (in mM) 20 Tris⅐HCl (pH 7.5), 150 NaCl, 1 disodium EDTA, 1 EGTA, 2.5 sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 sodium orthovanadate, and 1% Triton X-100, and complete protease inhibitor cocktail. Monoclonal antibody against nPKC⑀ (1:1,000) was added to each sample for overnight rotation at 4°C. After incubation, immune complexes were precipitated with protein A agarose beads, washed, resuspended in 20 l kinase buffer containing (in mM) 25 Tris⅐HCl (pH 7.5), 5 ␤-glycerophosphate, 2 DTT, 0.1 sodium orthovanadate, 10 magnesium chloride, and 10 Ci [␥-
32 P]ATP (New England Nuclear), and then incubated with 10 g myelin basic protein as a substrate at 30°C for 30 min. After incubation, the reaction was terminated by adding 2ϫ Laemmli sample buffer to the samples, and the samples were boiled for 5 min. Supernatants were subjected to SDS-PAGE (12% gels; Bio-Rad), and the gel was dried and subjected to autoradiography.
Statistical analysis. All results are expressed as means Ϯ SE. Net 1-h bicarbonate secretion refers to stimulated responses minus mean basal values. Data were analyzed by one-way ANOVA followed by Student-Newman-Keuls post hoc test or, when appropriate, by Student's t-tests using GraphPad Prism 2.0 (San Diego, CA). P Ͻ 0.05 was considered statistically significant.
RESULTS
Effect of PMA on basal duodenal mucosal bicarbonate secretion. After measuring basal duodenal bicarbonate secretion, different concentrations of PMA (10 Ϫ8 to 10 Ϫ5 M) were added serosally, and the incubation was continued for up to 2 h. Fig. 1 Effect of PMA on cAMP-stimulated duodenal bicarbonate secretion. cAMP is an important intracellular messenger regulating duodenal bicarbonate secretion (9) . Some studies have shown that PMA can potentiate chloride secretory responses evoked by cAMP in T84 (6), C127 (7), and pancreatic duct cells (36) . We therefore examined whether PMA had any effect on cAMP-stimulated duodenal bicarbonate secretion. When PMA (10 Ϫ5 M) and db-cAMP (10 Ϫ3 M) were added simultaneously to the serosal side of mouse duodenum, duodenal bicarbonate secretion and I sc were no different from those produced by db-cAMP in tissues treated only with the vehicle (Fig. 2, A and B) (P Ͼ 0.05). However, after a 1-h preincubation with PMA (10 Ϫ5 M), db-cAMPstimulated duodenal bicarbonate secretion and I sc responses were significantly potentiated, compared with the control group (Fig. 3, A and B) (P Ͻ 0.01). Moreover, the effect of PMA on db-cAMP-stimulated duodenal bicarbonate secretion was concentration-dependent (10 Ϫ8 to 10 Ϫ5 M, P Ͻ 0.05) (Fig. 4) . At the highest concentration of PMA, the effect of db-cAMP on bicarbonate secretion was increased by ϳ50%. For comparison, we assessed any effects of PMA on carbachol-and ST a -induced duodenal bicarbonate secretion. These agents act via calcium and cGMP, respectively. Moreover, there is evidence that at least part of their effect on bicarbonate secretion may be independent of the CFTR chloride channel. The results demonstrated that preincuba-tion with PMA (10 Ϫ5 M) for 1 h had no effect on either carbachol-or ST a -induced duodenal bicarbonate secretion (Fig. 5) .
Effects of isozyme-selective PKC inhibitors on the ability of PMA to potentiate transport responses to cAMP. To demonstrate which PKC isoform(s) are involved in the regulation of duodenal bicarbonate secretion, we first examined the effect of two PKC inhibitors, Gö 6983 and Ro 31-8220, which have been shown to inhibit differentially cPKC and nPKC isoforms. Neither drug altered bicarbonate secretion induced by dbcAMP by themselves (Fig. 6) . Likewise, serosal addition of Gö 6983 (10 Ϫ5 M), an inhibitor of PKC␣, -␥, -␤, and -␦, for 30 min before PMA, failed to reverse the potentiation of cAMPstimulated duodenal bicarbonate secretion induced by PMA. In contrast, the addition of Ro 31-8220 (5 ϫ 10 Ϫ6 M), an inhibitor of PKC⑀, -␣, -␤, and -␥, completely reversed the potentiation of cAMP-stimulated duodenal bicarbonate secretion induced by PMA (Fig. 6) .
Expression of PKC isoforms in murine duodenal mucosa. At least 11 isoforms of PKC have been identified. The presence of PKC␣, -␤, -␥, -␦, -⑀, -, -, and -/ isoforms in murine duodenal mucosa was investigated by Western blot analysis. With the use of specific antibodies against these isoforms, PKC␣ and -␥ in the conventional family, PKC⑀, -, and -in the novel family, and PKC/ in the atypical family were detected in murine duodenal mucosa. PKC␤ and -␦ were not reproducibly detected in these tissues (Fig. 7) .
Effects of PMA and PKC inhibitors on activity of PKC⑀. The pharmacological studies described above were consistent with the hypothesis that PKC⑀ is responsible for the ability of PMA to potentiate cAMP-stimulated duodenal bicarbonate secretion. We therefore made a further investigation of the effects of PMA and PKC inhibitors (Gö 6983 and Ro 31-8220) on the activity of this specific isozyme, shown to be present in the tissues (Fig. 7) . PMA concentration-and time-dependently increased the activity of PKC⑀. This was demonstrated by a steady increase in the intensity of the 19-kDa MBP band detected on autoradiograms of samples derived from in vitro kinase assays, reflective of PKC⑀ activity (Figs. 8 and 9 ). PKC⑀ kinase activity was increased significantly at a PMA concentration of 10 Ϫ7 M and maximally at 10 Ϫ5 M (Fig. 8) . In time course studies, PKC⑀ kinase activity was first notably increased after 30 min of exposure to PMA (10 Ϫ5 M) and reached a peak at 60 min ( Fig. 9) . Pretreatment with Ro 31-8220 (5 ϫ 10 Ϫ6 M) for 30 min before the addition of PMA completely inhibited PMAstimulated PKC⑀ activity, whereas Gö 6983 (10 Ϫ5 M) did not inhibit PMA-induced activation of PKC⑀ (Fig. 10) .
DISCUSSION
Duodenal bicarbonate secretion is currently accepted as a critical defense mechanism against acid-peptic injury (9, 13, 17) . This transport process is regulated via the activation of different signaling pathways. cAMP, Ca 2ϩ , and cGMP are three important positive regulators of duodenal bicarbonate secretion (8, 9) . PKC is a Ca 2ϩ -and phospholipid-dependent protein kinase and plays an important role in signal transduction in many systems, including the regulation of ion transport, cell growth, and differentiation. Immunohistochemistry has confirmed the presence of some PKC isoforms in the rat duodenum (20) . However, the role of PKC in duodenal bicarbonate secretion has not been fully elucidated.
In this study, we found that PMA, an activator of PKC, had no significant effect on basal duodenal bicarbonate secretion in mice. Previous studies have shown that PKC potentiated the chloride secretory response induced by cAMP in T84 (6), C127 (7), and pancreatic duct cells (36) . We therefore examined the effect of PMA on cAMP-stimulated duodenal bicarbonate secretion. We found that when PMA and db-cAMP were added simultaneously to the serosal side of mouse duodenum, PMA failed to alter db-cAMP-stimulated duodenal bicarbonate secretion. However, serosal pretreatment of the tissue with PMA for 1 h significantly potentiated db-cAMP-stimulated bicarbonate secretion. Moreover, the ability of PMA to potentiate secretion was concentration-dependent and consistent with the concentration-dependency for the effect of PMA on PKC activation in other intact tissues (24, 32) . Odes et al. (27) reported that the intravenous infusion of PMA into guinea pigs resulted in a marked stimulation of active duodenal bicarbonate secretion. This was accompanied by a time-dependent translocation of cytosolic, lipid-dependent PKC activity into the particulate fraction. Furukawa et al. (10) likewise found that luminal perfusion of PMA in rats increased basal duodenal bicarbonate secretion, and that staurosporine, an inhibitor of PKC, inhibited acid-induced duodenal bicarbonate secretion. These prior results indicated that PKC is involved in the regulation of duodenal bicarbonate secretion. However, in the present study, we found that PMA had no significant effect on basal duodenal bicarbonate secretion in mice as studied in vitro. This difference between our studies and the prior work of others may be accounted for by the presence in vivo of cAMP-dependent secretagogues that set a considerable basal tone for bicarbonate secretion, which could then be increased further by PMA.
The PKC family consists of at least 11 isoforms. Our Western blot analysis demonstrated that seven PKC isoforms, PKC␣, -␥, -⑀, -, -, and -/, are expressed in the duodenal mucosa of Swiss mice, representative of three major classes of PKC isoforms. PKC␤ and -␦ were not detected in duodenal mucosa in mice. The study of Balogh et al. (1) , however, showed that PKC␣, -␤, and -␦, but not PKC⑀ and -were expressed in rat duodenal mucosa. This discrepancy may be related to species or to methodological differences. To understand which isoforms of PKC participate in the regulation of duodenal bicarbonate secretion, we first took a pharmacological approach. This showed that Ro 31-8220 (an inhibitor active against PKC⑀, -␣, -␤, and -␥), but not Gö 6983 (an inhibitor active against PKC␣, -␤, -␥ and -␦), completely reversed the potentiating action of PMA on cAMP-stimulated duodenal bicarbonate secretion. These data implied that PKC⑀ was a candidate to mediate the effect of PMA on duodenal bicarbonate secretion. However, these pharmacological studies are complicated by the fact that no isoform-specific pharmacological inhibitors of PKC are currently available. Thus in addition to inhibiting PKC⑀, Ro 31-8220 is also an inhibitor of PKC␣, -␤, and -␥ (19, 38) . On the other hand, Gö 6983 was also shown to inhibit PKC␣, -␤, and -␥ but has no inhibitory effect on PKC⑀ (3, 11) . In addition, there is apparently no expression of PKC␤ in the duodenal mucosa of mice, at least in our hands. Similarly, a PKC/ is not directly activated by PMA. Therefore, by a process of elimination, we identified PKC⑀ as the most likely isoform to mediate the potentiating effect of PMA on duodenal bicarbonate secretion.
To further delineate the action of PKC⑀ in duodenal mucosa, we performed an in vitro kinase activity assay for Fig. 6 . Effect of PKC inhibitors on the ability of PMA to potentiate cAMPstimulated bicarbonate secretion. Mouse duodenal mucosae were incubated sequentially with Ro 31-8220 (5 ϫ 10 Ϫ6 M), Gö 6983 (10 Ϫ5 M), or the vehicle control (DMSO), followed 30 min later by PMA (10 Ϫ5 M) or vehicle, followed 1 h later by db-cAMP. Ro 31-8220 reversed the potentiating effect of PMA on cAMP-stimulated duodenal bicarbonate secretion, whereas Gö 6983 did not. Data are expressed as the net bicarbonate output stimulated by db-cAMP and are means Ϯ SE for at least 9 experiments. **Significantly different from control, P Ͻ 0.01; ϩϩsignificantly different from tissues treated with PMA alone or PMA ϩ Gö 6983, P Ͻ 0.01 by 1-way ANOVA with StudentNewman-Keuls post hoc test. Fig. 7 . Western blot analysis of conventional PKC (cPKC), atypical PKC (aPKC), and novel PKC (nPKC) isoforms in murine duodenal mucosa. Tissue lysates were subjected to electrophoresis through 7.5% SDS-PAGE and transferred to PVDF membranes. Membranes were probed with monoclonal antibodies specific for various PKC isoforms (␣, ␤, ␥, ⑀, ␦, , , , and ). Expression in murine duodenal mucosa (S) was assessed by comparison with molecular mass standards and comigration with positive control preparations of rabbit brain (P). PKC isoforms were detected through the use of an enhanced chemiluminescent methodology as described in MATERIALS AND METHODS. These Western blots are representative of 3 similar experiments. PKC⑀. PMA concentration-and time-dependently increased the activity of PKC⑀. The activity of PKC⑀ was markedly increased at 30 min after exposure to PMA, and was maximal at 60 min. Ro 31-8220, but not Gö 6983, completely inhibited the activation of PKC⑀ by PMA. When PMA and db-cAMP were added simultaneously to duodenal tissue, PMA failed to alter db-cAMP-stimulated duodenal bicarbonate secretion, whereas when it was added 1 h before db-cAMP, PMA potentiated db-cAMP-stimulated duodenal bicarbonate secretion. This is therefore consistent with the kinetics of PMA-induced PKC⑀ kinase activity in the tissue. We conclude that events downstream of PKC⑀ activation must exist in the tissues at the time of db-cAMP addition for augmented secretion to occur. Such events are presumably delayed in time after PKC⑀ activation, but could persist once initiated. This could account for seeming discrepancies in the details of the time courses for PKC activation and augmented secretion. In any event, these results further substantiate the role of PKC⑀ in the regulation of duodenal bicarbonate secretion. In the long term, molecular techniques will be needed to verify definitively the role of PKC⑀.
The precise mechanisms whereby PMA potentiates cAMPstimulated duodenal bicarbonate secretion also require additional study, but some speculations are possible. PKC is known to regulate CFTR. Several recent studies have shown that CFTR channel also plays an important role in regulating duodenal bicarbonate secretion (5, 14, 15, 29, 33) , and cAMP predominately regulates epithelial Cl Ϫ and HCO 3 Ϫ secretion in epithelia by activating CFTR. CFTR is a 1,480-amino acid protein with a unique structure characterized by three cytoplasmic domains, two nucleotide binding folds, and a regulatory domain that contains consensus sequences for phosphorylation by PKA and PKC (28) . In membrane patches excised from cells expressing CFTR, the addition of exogenous PKC resulted in a modest increase in CFTR channel activity and enhanced the rate and magnitude of subsequent PKA stimulation of open probability (35) . Jia et al. (18) found that PKCmediated phosphorylation not only potentiated CFTR opening in response to cAMP, but, in fact, was essential for acute PKA activation of CFTR channels. Thus one mechanism whereby PMA could potentiate cAMP-stimulated duodenal bicarbonate secretion would be by regulating CFTR channels. In addition, we found that PMA had no effect on carbachol-or ST a -induced duodenal bicarbonate secretion. Duodenal bicarbonate secretion induced by these agents involves pathways that are independent of CFTR (29) . Our results demonstrate that PKC likely has no effect on Ca 2ϩ -and cGMP-dependent duodenal bicarbonate secretion.
Considering PKC⑀ specifically, Liedtke and Cole (23) showed that this isoform regulated the function of CFTR in Calu-3 cells. On the other hand, Chow et al. (4) showed that PKC⑀ was activated in T84 cells in response to epidermal growth factor, and participated in the negative regulation of showed that PMA could inhibit cAMP-stimulated Cl Ϫ secretion in T84 cells by activating PKC⑀. This latter effect was apparently due to an increased rate of basolateral endocytosis in PMA-treated cells, resulting in the retrieval of transport proteins needed for the overall chloride secretory mechanism from the plasma membrane. In the present study, however, PKC⑀ was associated with an increase rather than a decrease in epithelial ion transport. This might suggest a different balance of positive (on CFTR) and negative (on basolateral transportors) effects of PKC⑀ on the machinery needed for bicarbonate vs. chloride secretion, or that specific phosphorylation events on CFTR might modulate its substrate specificity, or some combination of these and/or additional mechanisms.
In summary, the present study demonstrates that PKC [or at least PMA-sensitive isoform(s)] likely does not participate in basal duodenal bicarbonate secretion in mice, but potentiates cAMP-stimulated duodenal bicarbonate secretion. Western blot analysis showed the expression of PKC␣, -␥, -⑀, -, -, and -/ in duodenal mucosa in mice. Activation of PKC⑀ specifically regulates duodenal bicarbonate secretion. Our findings contribute to the understanding of the cellular mechanisms that underlie duodenal bicarbonate secretion, and additionally underscore the complexities and specificity of regulatory mechanisms for anion secretion in the mammalian intestine.
